Cargando…
Cross‐disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology
Neuromuscular junctions are primary pathological targets in the lethal motor neuron diseases spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Synaptic pathology and denervation of target muscle fibers has been reported prior to the appearance of clinical symptoms in mouse model...
Autores principales: | Comley, Laura H., Nijssen, Jik, Frost‐Nylen, Johanna, Hedlund, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063101/ https://www.ncbi.nlm.nih.gov/pubmed/26502195 http://dx.doi.org/10.1002/cne.23917 |
Ejemplares similares
-
Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
por: Nijssen, Jik, et al.
Publicado: (2017) -
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
por: Cappello, Valentina, et al.
Publicado: (2017) -
Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy
por: Williamson, R. T.
Publicado: (1907) -
Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
por: Krakora, Dan, et al.
Publicado: (2012) -
LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy
por: Nichterwitz, Susanne, et al.
Publicado: (2020)